Chicago Partners Investment Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.27M Buy
18,192
+35
+0.2% +$2.45K 0.04% 345
2025
Q1
$1.23M Sell
18,157
-631
-3% -$42.6K 0.04% 326
2024
Q4
$1.61M Buy
18,788
+1,283
+7% +$110K 0.05% 258
2024
Q3
$2.03M Buy
17,505
+28
+0.2% +$3.24K 0.07% 214
2024
Q2
$2.26M Buy
17,477
+83
+0.5% +$10.7K 0.09% 205
2024
Q1
$2.24M Sell
17,394
-487
-3% -$62.6K 0.1% 195
2023
Q4
$1.88M Sell
17,881
-2,801
-14% -$295K 0.09% 207
2023
Q3
$2.01M Sell
20,682
-1,044
-5% -$101K 0.11% 181
2023
Q2
$1.72M Buy
21,726
+146
+0.7% +$11.6K 0.09% 212
2023
Q1
$1.84M Buy
21,580
+1,480
+7% +$126K 0.11% 186
2022
Q4
$1.4M Sell
20,100
-2,844
-12% -$198K 0.09% 215
2022
Q3
$1.32M Hold
22,944
0.09% 192
2022
Q2
$1.33M Sell
22,944
-1,366
-6% -$79.2K 0.1% 189
2022
Q1
$1.26M Buy
24,310
+5,694
+31% +$295K 0.1% 179
2021
Q4
$913K Hold
18,616
0.06% 236
2021
Q3
$1.06M Hold
18,616
0.07% 216
2021
Q2
$831K Sell
18,616
-2,400
-11% -$107K 0.06% 242
2021
Q1
$779K Buy
21,016
+2,000
+11% +$74.1K 0.06% 236
2020
Q4
$692K Sell
19,016
-402
-2% -$14.6K 0.07% 223
2020
Q3
$634K Buy
19,418
+6,300
+48% +$206K 0.08% 197
2020
Q2
$442K Buy
13,118
+216
+2% +$7.28K 0.06% 232
2020
Q1
$407K Hold
12,902
0.06% 215
2019
Q4
$396K Hold
12,902
0.05% 240
2019
Q3
$350K Buy
+12,902
New +$350K 0.05% 234
2018
Q4
Sell
-6,288
Closed -$134K 713
2018
Q3
$134K Buy
6,288
+26
+0.4% +$554 0.02% 356
2018
Q2
$144K Buy
6,262
+5,536
+763% +$127K 0.02% 329
2018
Q1
$18K Sell
726
-158
-18% -$3.92K ﹤0.01% 663
2017
Q4
$24K Sell
884
-16
-2% -$434 ﹤0.01% 580
2017
Q3
$22K Sell
900
-740
-45% -$18.1K ﹤0.01% 611
2017
Q2
$32K Buy
+1,640
New +$32K 0.01% 455